# Tianjin Venture Capital

> Tianjin Venture Capital is a VC fund in Tianjin backing Manufacturing and Information Technology. See 107 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Tianjin, China
- Total investments: 107
- Last investment: Jun 2026
- Lead investor: 15%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/tianjin-venture-capital-co-ltd
- Website: http://www.tjvcm.com

Tianjin Venture Capital is an investment firm.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $413k–$15M |
| Series A | $202k–$31M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 30 | 28% |
| Information Technology | 16 | 15% |
| Biotechnology | 14 | 13% |
| Health Care | 13 | 12% |
| Industrial | 12 | 11% |

118 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 60 | 56% |
| Seed | 14 | 13% |
| Series A | 13 | 12% |
| Series B | 6 | 6% |
| Series C | 5 | 5% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 96 | 90% |
| United States | 1 | 1% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xingneng Xuanguang | Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology. | $73.9M | Series A | Jun 12, 2026 |  |
| YolTech Therapeutics | Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease. | $73.8M | Series C | May 29, 2026 |  |
| GasGene | GasGene ferments industrial waste gas to generate bulk chemicals. | $14.5M | Venture - Series Unknown | Mar 23, 2026 |  |
| Zhuji Dynamics | Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots | $200M | Series B | Jan 02, 2026 |  |
| Xingkan Jiuzhou | Xingkan Jiuzhou is a technology-based enterprise specializing in radio signal reception, demodulation, analysis, and transmitter location. |  | Seed | Sep 22, 2025 |  |
| YolTech Therapeutics | Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease. | $42.1M | Series B | Sep 11, 2025 |  |
| Diyou Precision | Diyou Precision is a precision equipment company specializing in the development, production, and sale of precision film-forming technology, core equipment fabrication, and system integration. |  | Series A | Aug 29, 2025 |  |
| Mech-Mind Robotics | Mech-Mind is dedicated to giving intelligence to industrial robots. Through core technologies such as machine vision (2D/3D), advanced programming models, fast environment awareness, intelligent decision making, and autonomous path planning, robots will no longer be a clumsy machine that can only repeat actions, but become available toeveryone and available everywhere. Smart helper. The company's core products are high-performance 3D cameras, visual AI algorithms and software, robot motion algorithms and software, and can provide reference designs and field services for a variety of typical applications. Mecamand's complete solution enables robot manufacturers and integrators to quickly upgrade their artificial intelligence capabilities to perform applications such as disordered object capture, visual guided unraveling, mixed palletizing, and precision positioning assembly. | $69.9M | Series D | Aug 26, 2025 |  |
| Xingneng Xuanguang | Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology. |  | Seed | Nov 29, 2024 |  |
| Xingneng Xuanguang | Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology. | $13.8M | Angel | Nov 29, 2024 |  |

10 of 107 investments shown.

## Co-investors
- [Haitang Fund](https://shizune.co/investors/profile/haitang-fund) — VC Fund, 6 deals together
- [Fortune Venture Capital](https://shizune.co/investors/profile/fortune-venture-capital) — VC Fund, 5 deals together
- [Shenzhen Capital Group](https://shizune.co/investors/profile/shenzhen-capital-group) — VC Fund, 4 deals together
- [Green Pine Capital Partners](https://shizune.co/investors/profile/green-pine-capital-partners) — VC Fund, 3 deals together
- [Tianchuang Capital](https://shizune.co/investors/profile/tianchuang-capital) — VC Fund, 3 deals together
- [AstraZeneca-CICC Venture Capital](https://shizune.co/investors/profile/astrazeneca-cicc-venture-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Life Science Investors in Asia](https://shizune.co/investors/life-science-investors-asia)
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)
- [Sustainability VC Funds in China](https://shizune.co/investors/sustainability-vc-funds-china)
- [Impact VC Funds in China](https://shizune.co/investors/impact-vc-funds-china)

## FAQ

### What does Tianjin Venture Capital invest in?

Tianjin Venture Capital invests primarily in Manufacturing, Information Technology and Biotechnology startups, most often at Funding Round and Seed stage. Most of the 107 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Tianjin Venture Capital's check size?

Tianjin Venture Capital typically joins rounds of $413k–$15M at Seed and $202k–$31M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tianjin Venture Capital participates in.

### When did Tianjin Venture Capital last invest?

The most recent investment recorded for Tianjin Venture Capital closed in Jun 2026. Shizune tracks 107 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co